Bacterial Disease Diagnostics Market Trends

  • Report ID: 5206
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Market Trends

Growth Drivers

  • Rising Government Initiatives for Better Healthcare– In 2021, the World Health Organization started the initiative Global Health and Peaces to address the critical health needs of people and to address 70% of disease outbreaks under this program. Bacterial illness diagnostics are critical for early diagnosis and prompt management of infections, which coincides with the government's preventative healthcare aims.
  • Increasing Emissions from Vehicles– Motor vehicles emit around 1.5 billion tonnes of greenhouse gases (GHGs) directly into the atmosphere each year. Poor air quality is linked to respiratory problems as well as compromised immune systems, rendering people more susceptible to bacterial illnesses. Therefore, the growing vehicular emissions will increase the need for bacterial disease diagnostics to treat infections.
  • Growing Need for Wastewater Treatment- Around 50% of wastewater generated in the world is carefully treated. To test the effectiveness of water and wastewater treatment, the need for bacterial diagnosis becomes highly important. Screening indicator bacteria levels in wastewater aids in making sure that the outcome of residential and industrial wastewater treatment is safe for discharge into the environment.

Challenges

  • Lack of Skilled Personnel and Adequate Infrastructure- Many developing countries do not have well-established infrastructure for advanced diagnostic technologies. Moreover, there is a lack of funds and skilled people to carry on the procedure effectively.
  • Low Awareness Regarding the Diagnosis of Bacterial Diseases
  • High Cost of Manufacturing

Bacterial Disease Diagnostics Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

7.8%

Base Year Market Size (2023)

USD 3.23 Billion

Forecast Year Market Size (2036)

USD 8.59 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5206
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of bacterial disease diagnostics is estimated at USD 3.46 Billion.

The bacterial disease diagnostics market size was valued at USD 3.23 Billion in 2023 and is set to cross USD 8.59 Billion by the end of 2036, expanding at more than 7.8% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

North America industry is projected to be the largest with a share of about 35% by 2036, due to rising instances of fatal infections caused by bacteria in the region.

bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample